Skip to content

OMNI Hip H3-53204Recalls & reported problems

Omni Life Science, Inc. · Biolox Delta Femoral Head 32 mm +4mm · Class 2 · Implant

All models of OMNI Hip (31)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00841690119241), received between Aug 19, 2020 and Aug 19, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Infusion or Flow Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Infusion or Flow Problem1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 19, 2020Infusion or Flow Problem; Infusion or Flow Problem

    A COMPLAINT WAS INITIATED FOR A PATIENT WHO UNDERWENT A HIP REVISION SURGERY ON (B)(6) 2020. THE ORIGINAL SURGERY IS DATED (B)(6) 2019. THE REASON FOR REVISION IS REPORTED MALALIGNMENT. DURING THE REVISION, THE ORIGINAL CERAMIC FEMORAL HEAD WAS REMOVED AND REPLACED FOR A NEW COMPONENT.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 10425146 ↗

Other Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented devices

All Prosthesis, hip, semi-constrained, metal/ceramic/polymer, cemented or non-porous, uncemented devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page